Search Results

There are 4338 results for: content related to: UGT1A1*6 , 1A7*3 , and 1A9*22 genotypes predict severe neutropenia in FOLFIRI -treated metastatic colorectal cancer in two prospective studies in Japan

  1. Combined UGT1A1 and UGT1A7 variant alleles are associated with increased risk of Gilbert’s syndrome in Taiwanese adults

    Clinical Genetics

    Volume 72, Issue 4, October 2007, Pages: 321–328, H-C Teng, M-J Huang, K-S Tang, S-S Yang, C-S Tseng and C-S Huang

    Version of Record online : 6 AUG 2007, DOI: 10.1111/j.1399-0004.2007.00873.x

  2. You have free access to this content
    Gilbert syndrome redefined: A complex genetic haplotype influences the regulation of glucuronidation

    Hepatology

    Volume 55, Issue 6, June 2012, Pages: 1912–1921, Ursula Ehmer, Sandra Kalthoff, Bastian Fakundiny, Brigitte Pabst, Nicole Freiberg, Ronald Naumann, Michael P. Manns and Christian P. Strassburg

    Version of Record online : 23 APR 2012, DOI: 10.1002/hep.25561

  3. You have full text access to this Open Access content
    Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer

    Cancer Science

    Volume 97, Issue 11, November 2006, Pages: 1255–1259, Kazuhiro Araki, Ken-ichi Fujita, Yuichi Ando, Fumio Nagashima, Wataru Yamamoto, Hisashi Endo, Toshimichi Miya, Keiji Kodama, Masaru Narabayashi and Yasutsuna Sasaki

    Version of Record online : 12 SEP 2006, DOI: 10.1111/j.1349-7006.2006.00321.x

  4. You have full text access to this OnlineOpen article
    Pregnane-x-receptor controls hepatic glucuronidation during pregnancy and neonatal development in humanized UGT1 mice

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 658–667, Shujuan Chen, Mei-Fei Yueh, Ronald M. Evans and Robert H. Tukey

    Version of Record online : 11 JUN 2012, DOI: 10.1002/hep.25671

  5. Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer

    The Journal of Clinical Pharmacology

    Volume 56, Issue 4, April 2016, Pages: 461–473, Andrew K. L. Goey, Tristan M. Sissung, Cody J. Peer, Jane B. Trepel, Min-Jung Lee, Yusuke Tomita, Sheryl Ehrlich, Christine Bryla, Sanjeeve Balasubramaniam, Richard Piekarz, Seth M. Steinberg, Susan E. Bates and William D. Figg

    Version of Record online : 9 NOV 2015, DOI: 10.1002/jcph.625

  6. Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk

    Head & Neck

    Volume 35, Issue 6, June 2013, Pages: 858–867, Martin Lacko, Adri C. Voogd, Hennie M. J. Roelofs, Rene H. M. te Morsche, Michel B. Oude Ophuis, Wilbert H. M. Peters and Johannes J. Manni

    Version of Record online : 19 JUN 2012, DOI: 10.1002/hed.23054

  7. Genotype of UGT1A1 and phenotype correlation between Crigler–Najjar syndrome type II and Gilbert syndrome

    Journal of Gastroenterology and Hepatology

    Volume 31, Issue 2, February 2016, Pages: 403–408, Yoshihiro Maruo, Sayuri Nakahara, Takahide Yanagi, Akitaka Nomura, Yu Mimura, Katsuyuki Matsui, Hiroshi Sato and Yoshihiro Takeuchi

    Version of Record online : 28 JAN 2016, DOI: 10.1111/jgh.13071

  8. In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans

    The Journal of Clinical Pharmacology

    Volume 55, Issue 9, September 2015, Pages: 1061–1072, Stephan Francke, Rao N. V. S. Mamidi, Bhavna Solanki, Ellen Scheers, Andrew Jadwin, Reyna Favis and Damayanthi Devineni

    Version of Record online : 20 MAY 2015, DOI: 10.1002/jcph.506

  9. The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers

    Clinical Pharmacology & Therapeutics

    Volume 81, Issue 3, March 2007, Pages: 392–400, E Lévesque, R Delage, M-O Benoit-Biancamano, P Caron, O Bernard, F Couture and C Guillemette

    Version of Record online : 24 JAN 2007, DOI: 10.1038/sj.clpt.6100073

  10. You have free access to this content
    Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk

    Cancer

    Volume 98, Issue 4, 15 August 2003, Pages: 872–880, Abul Elahi, Jean Bendaly, Zhong Zheng, Joshua E. Muscat, John P. Richie Jr., Stimson P. Schantz and Philip Lazarus

    Version of Record online : 1 JUL 2003, DOI: 10.1002/cncr.11587

  11. The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: Haplotype associations and gene–environment interactions

    Genes, Chromosomes and Cancer

    Volume 53, Issue 6, June 2014, Pages: 454–466, Andrea Y. Angstadt, Terryl J. Hartman, Samuel M. Lesko, Joshua E. Muscat, Junjia Zhu, Carla J. Gallagher and Philip Lazarus

    Version of Record online : 12 FEB 2014, DOI: 10.1002/gcc.22157

  12. UGT1A9 −275T>A/−2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus-Treated Kidney Transplant Patients

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 3, September 2009, Pages: 319–327, R H N van Schaik, M van Agteren, J W de Fijter, A Hartmann, J Schmidt, K Budde, D Kuypers, Y Le Meur, M van der Werf, R Mamelok and T van Gelder

    Version of Record online : 3 JUN 2009, DOI: 10.1038/clpt.2009.83

  13. You have free access to this content
    Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer

    British Journal of Clinical Pharmacology

    Volume 78, Issue 5, November 2014, Pages: 1067–1075, Ana B. Santoro, Daniela D. Vargens, Mateus de Camargo Barros Filho, Daniel A. Bulzico, Luiz Paulo Kowalski, Ricardo M. R. Meirelles, Daniela P. Paula, Ronaldo R. S. Neves, Cencita N. Pessoa, Claudio J. Struchine and Guilherme Suarez-Kurtz

    Version of Record online : 20 OCT 2014, DOI: 10.1111/bcp.12437

  14. You have free access to this content
    Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4

    Hepatology

    Volume 39, Issue 4, April 2004, Pages: 970–977, Ursula Ehmer, Arndt Vogel, Jan Karl Schütte, Britta Krone, Michael P. Manns and Christian P. Strassburg

    Version of Record online : 25 MAR 2004, DOI: 10.1002/hep.20131

  15. You have full text access to this OnlineOpen article
    Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B)

    Thoracic Cancer

    Volume 7, Issue 4, July 2016, Pages: 467–472, Minoru Fukuda, Takayuki Suetsugu, Midori Shimada, Takeshi Kitazaki, Kohji Hashiguchi, Junji Kishimoto, Taishi Harada, Takashi Seto, Noriyuki Ebi, Koichi Takayama, Kenji Sugio, Hiroshi Semba, Yoichi Nakanishi and Yukito Ichinose

    Version of Record online : 11 MAY 2016, DOI: 10.1111/1759-7714.12360

  16. You have free access to this content
    The role of chrysin and the Ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 349–360, Jessica A. Bonzo, Alain Bélanger and Robert H. Tukey

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21481

  17. You have free access to this content
    Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing

    Clinical Pharmacology & Therapeutics

    Volume 99, Issue 4, April 2016, Pages: 363–369, RS Gammal, MH Court, CE Haidar, OF Iwuchukwu, AH Gaur, M Alvarellos, C Guillemette, JL Lennox, M Whirl-Carrillo, SS Brummel, MJ Ratain, TE Klein, BR Schackman, KE Caudle and DW Haas

    Version of Record online : 9 NOV 2015, DOI: 10.1002/cpt.269

  18. UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 1, January 2010, Pages: 65–73, S Riedmaier, K Klein, U Hofmann, J E Keskitalo, P J Neuvonen, M Schwab, M Niemi and U M Zanger

    Version of Record online : 30 SEP 2009, DOI: 10.1038/clpt.2009.181

  19. Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications

    Clinical Pharmacology & Therapeutics

    Volume 96, Issue 3, September 2014, Pages: 324–339, C Guillemette, É Lévesque and M Rouleau

    Version of Record online : 12 JUN 2014, DOI: 10.1038/clpt.2014.126

  20. Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians

    Oral Diseases

    Volume 16, Issue 8, November 2010, Pages: 760–768, R Sharma, M Ahuja, NK Panda and M Khullar

    Version of Record online : 30 MAY 2010, DOI: 10.1111/j.1601-0825.2010.01683.x